- 期刊
Minimally Invasive Surgery for Renal Cell Carcinoma
腎臟癌之微創手術
摘要
微創手術在過去二十年期間被廣泛應用到各種泌尿外科手術上而免除了病人傳統開腹手術的傷口疼痛及加速恢復。目前根除性腹腔鏡以及後腹腔鏡腎臟切除手術用於治療腎臟癌被認為是一種安全的手術且對於癌症控制有與傳統手術相當的效果。與傳統的開腹手術相比較，微創腹腔鏡以及後腹腔鏡手術不僅在手術中對於手術視野有放大之效果以至於減少對組織和器官之損傷，對術後疼痛及傷口美觀也是影響最小。此外腹腔鏡部分腎臟切除手術近年來對於適合甚至是對側腎臟功能正常之病人也逐漸受到重視，也能夠達到不錯的癌症的長期存活率。隨著新技術及器械的不斷改進，微創手術應用在腎臟癌患者也將會扮演更加重要角色。近年來越來越多文獻報告提到以單孔手術以及經自然孔道內視鏡手術治療腎臟癌。本文將針對微創手術用於腎臟癌之治療做完整的評論。
並列摘要
In the past two decades, laparoscopic procedures have been applied to various surgeries in the urology field to minimize the postoperative pain and convalescence period. Laparoscopic and retroperitoneoscopic radical nephrectomy are popular and safe procedures having oncologic control comparable with that of conventional operation. By magnification of the surgical exposure, surgeons minimize the risk to damage to surrounding organ and tissue and improve the cosmetic and perioperative outcomes, including pain. On the other hand, the value of laparoscopic partial surgery has been well-established for selected patients even in the presence of a normally functioning contralateral kidney. The results of nephron-sparing surgery also provide comparable long-term survival. With the advances of technology and instruments, minimally invasive therapy will play an important role. Recently, single-port radical nephrectomy and natural orifice transluminal endoscopic surgery for renal cell carcinoma (RCC) have been reported. This review will highlight the long-term outcomes and recent developments in minimally invasive surgeries for RCC.